Coarse composition suffices: tabular in-context learning for multi-activity antimicrobial peptide profiling
Not on the map. Why?
Abstract (arXiv)
Antimicrobial peptides (AMPs) often act against multiple pathogen classes, making multi-label activity prediction a more realistic screening target than binary antimicrobial classification. The ESCAPE benchmark formalizes this setting, but leading approaches typically rely on multimodal, structure-conditioned deep models that are costly to train and tune. We show that a simple, sequence-only pipeline can match and surpass these methods by combining 330 interpretable sequence descriptors with TabPFN, a tabular foundation model that performs in-context prediction in a single forward pass without gradient-based training or hyperparameter search. On ESCAPE (82,359 peptides; five labels), a label-powerset TabPFN model achieves mAP-5 = 77.8%, improving on the previously best reported 72.1%. A probabilistic classifier chain is the first method to match or exceed the best published average precision on each of the five labels simultaneously. The gains persist under the prior state-of-the-art single-fold training protocol, indicating they are not a training-set-size artefact, and are largest for remote homologues (+11.2 points below 30% sequence identity). Ablations further show that predicted structure is unnecessary at inference and that performance is not driven by any single descriptor family: ten global physicochemical scalars recover 91% of full-feature performance. Finally, explicitly modelling label dependence yields targeted benefits for scarce activities and supports ranking which activity to assay next from partial positive evidence.
Key facts. No citing papers in the map yet (data through 14 Oct 2026). Builds on 4 of its 36 references that are in the map. First posted on arXiv 31 Aug 2026.
Builds on
4 of 36 references.
References · 4
- 2022TabPFN: A Transformer That Solves Small Tabular Classification Problems in a Secondcited by 674
- 2021Transformers Can Do Bayesian Inferencecited by 360
- 2018Learning from positive and unlabeled data: a surveycited by 219
- 2025A Standardized Benchmark for Multilabel Antimicrobial Peptide Classificationcited by 2
Built on by
Not cited yet.